dynactin1 Search Results


N/A
Dynactin 1 Monoclonal Antibody for Western Blot, IP
  Buy from Supplier

92
Santa Cruz Biotechnology α p150
A – D A phosphomimetic mutation in BICD2 Ser102 (BICD2 S102D) results in increased dynein and dynactin binding to BICD2. A The indicated GFP-fusion proteins were immunoprecipitated ( IP ) from HeLa cells and analyzed by western blot ( W ) to detect dynein and dynactin (using respectively anti-dynein intermediate chain, DIC, and <t>anti-p150</t> antibodies), plus GFP. DIC and p150 levels in the corresponding extracts are shown in the lower panel. B Normal <t>IgG</t> (NIgG) and anti-DIC immunoprecipitates from extracts expressing the indicated GFP-fusion proteins proved by western blot (W) with the indicated antibodies. Levels of GFP-fusion proteins plus p150 in the corresponding extracts are shown in the lower panel. C , D Quantification of the previous results. Top, DIC intensity/GFP-BICD2 intensity in the immunoprecipitates; mean ± SD of three independent experiments (corresponding to A ). Bottom, GFP-BICD2 intensity/DIC intensity in the immunoprecipitates; mean ± SD of two independent experiments (corresponding to B ). Statistical significance analyzed using one-way ANOVA with post hoc analysis (no correction for multiple comparations, Fisher’s LSD test). In ( C ), WT vs. S102A, P = 0.4380 (n.s.); WT vs. S102D, P = 0.0.232 (*); WT vs. 1-575, P < 0.0001 (***); S102A vs. S102D, P = 0.0068 (**). In ( D ), WT vs. S102A, P = 0.8631 (n.s); WT vs. S102D, P < 0.0001 (***); S102A vs. S102D, P < 0.0001 (***). E A phosphomimetic mutation in BICD2 Ser102 (BICD2 S102D) results in increased dynein mobility towards the centrosomes as detected by mitochondria relocalization and clustering. Different GFP-fusion proteins were targeted to mitochondria through a C-terminal mitochondria-targeting sequence domain (MTD) in U2OS cells. Representative immunofluorescence images are shown for each polypeptide, stained for GFP, Tom20, as a mitochondrial marker, and DAPI. Note that the S102D mutation favors clustering in a similar manner to the constitutively active BICD2 N-terminus (BICD2 1–575). Scale bar, 10 µm. See also Supplementary Fig. , showing that clustering happens around the centrosomes. Quantification of the percentage of cells with clustered mitochondria (as defined as cells in which most mitochondria are spatially grouped in one or few clusters in the cytoplasm) for each different GFP-fusion form is shown ( n = 3 biological replicates, 50 cells each; individual replicate means plus mean of replicates ± SD are shown; statistical significance analyzed using a Chi square test, with a two-sided P value; WT vs. S102A, P = 0.0464 (*); WT vs. S102D, P = 0.0010 (**); WT vs. 1–575, P < 0.0001 (***); S012A vs. S102D P < 0.0001 (***)). Expression levels of the different polypeptides as detected by western blot are shown.
α P150, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dynactin1/Dynactin+1+Antibody/pmc10140047-484-69-73
Average 92 stars, based on 1 article reviews
α p150 - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

91
Addgene inc hsp70 mkate2 dynactin
( A ) Schematic of mosaic Ath5 expression in the retina (green) at 28 hpf. Injection of ath5:GFP-CAAX construct at 1 cell stage. ( B ) Example of an asymmetric multipotent progenitor division with regards to Ath5 expression onset. <t>hsp70:H2B-RFP</t> (nuclei, grey), <t>hsp70:mkate2-ras</t> (cell membrane, grey), ath5:GFP-CAAX (Ath5, green). Dashed lines show apical and basal sides of the retinal neuroepithelium. Scale bar, 10 μm. Magenta and yellow dots label sister cells. ( C–C’ ) Schematics of multipotent progenitor cells dividing asymmetrically ( C ) or symmetrically ( C’ ) with regards to Ath5 expression. ( D ) Distribution of asymmetric vs symmetric divisions observed in live imaging experiments. N = number of embryos, n = number of divisions. ( E ) Ath5+ cells (grey) at 36 hpf in control (left) vs Notch inhibition (right). Scale bar, 50 μm. The yellow line delimits the apical side of the retinal neuroepithelium. ( F ) Ath5+ cells (grey) at 48 hpf in control (left) vs Notch inhibition (right). Scale bar, 50 μm. The yellow line delimits the apical side of the retinal neuroepithelium. ( G ) Schematic of retinal neuroepithelium measurements at 48 hpf, ( G’ ) retinal thickness control vs Notch inhibition, ( G’’ ) retinal diameter control vs Notch inhibition. Mann-Whitney test used for comparison. Vertical bars represent standard deviation. ( H ) Example of symmetric progenitor division upon Notch inhibition. hsp70:H2B-RFP (nuclei, grey), ath5:GFP-CAAX (Ath5, green). Dashed lines show apical and basal sides of the retinal neuroepithelium. Scale bar, 10 μm. Magenta and yellow dots label sister cells. ( I ) Distribution of asymmetric vs symmetric divisions observed in live imaging experiments in Notch inhibition compared to controls. Figure 1—source data 1. Source data for panels G’,G’’.
Hsp70 Mkate2 Dynactin, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dynactin1/hsp70%3A+mKate2+dynactin1-811+(Plasmid+%23105970)/pmc07679139-17-4-11
Average 91 stars, based on 1 article reviews
hsp70 mkate2 dynactin - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier

90
Ribobio co dctn1 (dynactin1)-specific small interfering rnas (sirnas)
( A ) Schematic of mosaic Ath5 expression in the retina (green) at 28 hpf. Injection of ath5:GFP-CAAX construct at 1 cell stage. ( B ) Example of an asymmetric multipotent progenitor division with regards to Ath5 expression onset. <t>hsp70:H2B-RFP</t> (nuclei, grey), <t>hsp70:mkate2-ras</t> (cell membrane, grey), ath5:GFP-CAAX (Ath5, green). Dashed lines show apical and basal sides of the retinal neuroepithelium. Scale bar, 10 μm. Magenta and yellow dots label sister cells. ( C–C’ ) Schematics of multipotent progenitor cells dividing asymmetrically ( C ) or symmetrically ( C’ ) with regards to Ath5 expression. ( D ) Distribution of asymmetric vs symmetric divisions observed in live imaging experiments. N = number of embryos, n = number of divisions. ( E ) Ath5+ cells (grey) at 36 hpf in control (left) vs Notch inhibition (right). Scale bar, 50 μm. The yellow line delimits the apical side of the retinal neuroepithelium. ( F ) Ath5+ cells (grey) at 48 hpf in control (left) vs Notch inhibition (right). Scale bar, 50 μm. The yellow line delimits the apical side of the retinal neuroepithelium. ( G ) Schematic of retinal neuroepithelium measurements at 48 hpf, ( G’ ) retinal thickness control vs Notch inhibition, ( G’’ ) retinal diameter control vs Notch inhibition. Mann-Whitney test used for comparison. Vertical bars represent standard deviation. ( H ) Example of symmetric progenitor division upon Notch inhibition. hsp70:H2B-RFP (nuclei, grey), ath5:GFP-CAAX (Ath5, green). Dashed lines show apical and basal sides of the retinal neuroepithelium. Scale bar, 10 μm. Magenta and yellow dots label sister cells. ( I ) Distribution of asymmetric vs symmetric divisions observed in live imaging experiments in Notch inhibition compared to controls. Figure 1—source data 1. Source data for panels G’,G’’.
Dctn1 (Dynactin1) Specific Small Interfering Rnas (Sirnas), supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dynactin1/dctn1++dynactin1++specific+small+interfering+rnas++sirnas+/pm37884867-38-46-52
Average 90 stars, based on 1 article reviews
dctn1 (dynactin1)-specific small interfering rnas (sirnas) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Becton Dickinson anti-dynactin 1 mouse monoclonal antibody
( A ) Schematic of mosaic Ath5 expression in the retina (green) at 28 hpf. Injection of ath5:GFP-CAAX construct at 1 cell stage. ( B ) Example of an asymmetric multipotent progenitor division with regards to Ath5 expression onset. <t>hsp70:H2B-RFP</t> (nuclei, grey), <t>hsp70:mkate2-ras</t> (cell membrane, grey), ath5:GFP-CAAX (Ath5, green). Dashed lines show apical and basal sides of the retinal neuroepithelium. Scale bar, 10 μm. Magenta and yellow dots label sister cells. ( C–C’ ) Schematics of multipotent progenitor cells dividing asymmetrically ( C ) or symmetrically ( C’ ) with regards to Ath5 expression. ( D ) Distribution of asymmetric vs symmetric divisions observed in live imaging experiments. N = number of embryos, n = number of divisions. ( E ) Ath5+ cells (grey) at 36 hpf in control (left) vs Notch inhibition (right). Scale bar, 50 μm. The yellow line delimits the apical side of the retinal neuroepithelium. ( F ) Ath5+ cells (grey) at 48 hpf in control (left) vs Notch inhibition (right). Scale bar, 50 μm. The yellow line delimits the apical side of the retinal neuroepithelium. ( G ) Schematic of retinal neuroepithelium measurements at 48 hpf, ( G’ ) retinal thickness control vs Notch inhibition, ( G’’ ) retinal diameter control vs Notch inhibition. Mann-Whitney test used for comparison. Vertical bars represent standard deviation. ( H ) Example of symmetric progenitor division upon Notch inhibition. hsp70:H2B-RFP (nuclei, grey), ath5:GFP-CAAX (Ath5, green). Dashed lines show apical and basal sides of the retinal neuroepithelium. Scale bar, 10 μm. Magenta and yellow dots label sister cells. ( I ) Distribution of asymmetric vs symmetric divisions observed in live imaging experiments in Notch inhibition compared to controls. Figure 1—source data 1. Source data for panels G’,G’’.
Anti Dynactin 1 Mouse Monoclonal Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dynactin1/anti+dynactin+1+mouse+monoclonal+antibody/pm32142134-45-45-52
Average 90 stars, based on 1 article reviews
anti-dynactin 1 mouse monoclonal antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Becton Dickinson mouse dynactin 1
Fignl1 directly binds the dynein/dynactin motor adaptor bicd1 in a protein complex including KIF1Bβ and dynactin 1. (A) Schematic representation of Ms_fignl1, Ms_bicd1, and their respective binding domains identified through a yeast two-hybrid screen (Y2H; black arrows). Specific domains are shown as boxes. Numbers indicate amino acids that delineate domain frontiers. AAA, ATPase domain; CC1, CC2, and CC3, coil-coiled domains. (B) COS-7 cells transfected with GFP-Ms_bicd1 and Dr_Fignl1-HA, and immunolabeled with HA and GFP antibodies. Dashed line delimits the transfected cell. Bottom panels represent higher magnifications of boxed regions in corresponding upper panels. Arrowheads indicate colocalization between HA-Fignl1 and GFP-bicd1 onto cytoplasmic vesicles. Scale bars, 10 µm. (C) Fignl1 associates with bicd1. Co-IP of Fignl1 isoforms and bicd1 from protein extracts of COS-7 cells transfected with GFP-Ms_bicd1 or GFP, Ms_ HA-fignl1, Dr_Fignl1-HA, or Dr_Fignl1Δ1-113-HA. (D) KIF1Bβ associates with bicd1. Co-IP of KIF1Bβ and bicd1 from protein extracts of COS-7 cells transfected with YFP-Hu_KIF1Bβ and Flag-Ms_bicd1. (E and F) Fignl1 is part of a protein complex including KIF1Bβ and the dynein adaptors bicd1 (E) and <t>dynactin</t> <t>1</t> (F). (E) Left-hand well: Co-IP of exogenous Fignl1 and bicd1 with endogenous kif1b from protein extracts of COS-7 cells transfected with Dr_Fignl1-HA and GFP-Ms_bicd1. Middle and right-hand wells: Co-IP of exogenous Fignl1, bicd1, and KIF1Bβ from protein extracts of COS-7 cells transfected with Dr_Fignl1-HA, Flag-Ms_bicd1, and YFP-Hu_KIF1Bβ or GFP. Immunoprecipitations were performed with GFP-trap (C–F), KIF1B (E), or HA (F) antibodies. Immunoprecipitated and coimmunoprecipitated proteins were revealed by Western blot using anti-tag or KIF1B and dynactin 1 antibodies or by Ponceau staining. IP, immunoprecipitation; WB, Western blot.
Mouse Dynactin 1, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dynactin1/mouse+dynactin+1+antibody/pmc06781435-160-46-50
Average 90 stars, based on 1 article reviews
mouse dynactin 1 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

N/A
Mouse Monoclonal antibody to Dynactin 1 Isotype Note: IgG2b Host Note: Mouse Conjugation Note: Unconjugated Reactivity Note: Bovine, Human, Mouse, Pig Application Note: ELISA, WB, IF/ICC
  Buy from Supplier


N/A
Mouse monoclonal Dynactin 1 antibody (N-terminus)
  Buy from Supplier

N/A
Boster Bio Anti-Dynactin 1 (N-terminus) monoclonal DCTN1 Antibody catalog # M02175. Tested in WB,IP applications. This antibody reacts with Human.
  Buy from Supplier

N/A
CRISPR/Cas9 KO Plasmids consists of Dynactin 1-specific 20 nt guide RNA sequences derived from the GeCKO (v2) library. For CRISPR gene knockout, gRNA sequences direct the Cas9 protein to induce a site-specific double strand break
  Buy from Supplier

N/A
CRISPR/Cas9 KO Plasmids consists of Dynactin 1-specific 20 nt guide RNA sequences derived from the GeCKO (v2) library. For CRISPR gene knockout, gRNA sequences direct the Cas9 protein to induce a site-specific double strand break
  Buy from Supplier

Image Search Results


A – D A phosphomimetic mutation in BICD2 Ser102 (BICD2 S102D) results in increased dynein and dynactin binding to BICD2. A The indicated GFP-fusion proteins were immunoprecipitated ( IP ) from HeLa cells and analyzed by western blot ( W ) to detect dynein and dynactin (using respectively anti-dynein intermediate chain, DIC, and anti-p150 antibodies), plus GFP. DIC and p150 levels in the corresponding extracts are shown in the lower panel. B Normal IgG (NIgG) and anti-DIC immunoprecipitates from extracts expressing the indicated GFP-fusion proteins proved by western blot (W) with the indicated antibodies. Levels of GFP-fusion proteins plus p150 in the corresponding extracts are shown in the lower panel. C , D Quantification of the previous results. Top, DIC intensity/GFP-BICD2 intensity in the immunoprecipitates; mean ± SD of three independent experiments (corresponding to A ). Bottom, GFP-BICD2 intensity/DIC intensity in the immunoprecipitates; mean ± SD of two independent experiments (corresponding to B ). Statistical significance analyzed using one-way ANOVA with post hoc analysis (no correction for multiple comparations, Fisher’s LSD test). In ( C ), WT vs. S102A, P = 0.4380 (n.s.); WT vs. S102D, P = 0.0.232 (*); WT vs. 1-575, P < 0.0001 (***); S102A vs. S102D, P = 0.0068 (**). In ( D ), WT vs. S102A, P = 0.8631 (n.s); WT vs. S102D, P < 0.0001 (***); S102A vs. S102D, P < 0.0001 (***). E A phosphomimetic mutation in BICD2 Ser102 (BICD2 S102D) results in increased dynein mobility towards the centrosomes as detected by mitochondria relocalization and clustering. Different GFP-fusion proteins were targeted to mitochondria through a C-terminal mitochondria-targeting sequence domain (MTD) in U2OS cells. Representative immunofluorescence images are shown for each polypeptide, stained for GFP, Tom20, as a mitochondrial marker, and DAPI. Note that the S102D mutation favors clustering in a similar manner to the constitutively active BICD2 N-terminus (BICD2 1–575). Scale bar, 10 µm. See also Supplementary Fig. , showing that clustering happens around the centrosomes. Quantification of the percentage of cells with clustered mitochondria (as defined as cells in which most mitochondria are spatially grouped in one or few clusters in the cytoplasm) for each different GFP-fusion form is shown ( n = 3 biological replicates, 50 cells each; individual replicate means plus mean of replicates ± SD are shown; statistical significance analyzed using a Chi square test, with a two-sided P value; WT vs. S102A, P = 0.0464 (*); WT vs. S102D, P = 0.0010 (**); WT vs. 1–575, P < 0.0001 (***); S012A vs. S102D P < 0.0001 (***)). Expression levels of the different polypeptides as detected by western blot are shown.

Journal: Nature Communications

Article Title: BICD2 phosphorylation regulates dynein function and centrosome separation in G2 and M

doi: 10.1038/s41467-023-38116-1

Figure Lengend Snippet: A – D A phosphomimetic mutation in BICD2 Ser102 (BICD2 S102D) results in increased dynein and dynactin binding to BICD2. A The indicated GFP-fusion proteins were immunoprecipitated ( IP ) from HeLa cells and analyzed by western blot ( W ) to detect dynein and dynactin (using respectively anti-dynein intermediate chain, DIC, and anti-p150 antibodies), plus GFP. DIC and p150 levels in the corresponding extracts are shown in the lower panel. B Normal IgG (NIgG) and anti-DIC immunoprecipitates from extracts expressing the indicated GFP-fusion proteins proved by western blot (W) with the indicated antibodies. Levels of GFP-fusion proteins plus p150 in the corresponding extracts are shown in the lower panel. C , D Quantification of the previous results. Top, DIC intensity/GFP-BICD2 intensity in the immunoprecipitates; mean ± SD of three independent experiments (corresponding to A ). Bottom, GFP-BICD2 intensity/DIC intensity in the immunoprecipitates; mean ± SD of two independent experiments (corresponding to B ). Statistical significance analyzed using one-way ANOVA with post hoc analysis (no correction for multiple comparations, Fisher’s LSD test). In ( C ), WT vs. S102A, P = 0.4380 (n.s.); WT vs. S102D, P = 0.0.232 (*); WT vs. 1-575, P < 0.0001 (***); S102A vs. S102D, P = 0.0068 (**). In ( D ), WT vs. S102A, P = 0.8631 (n.s); WT vs. S102D, P < 0.0001 (***); S102A vs. S102D, P < 0.0001 (***). E A phosphomimetic mutation in BICD2 Ser102 (BICD2 S102D) results in increased dynein mobility towards the centrosomes as detected by mitochondria relocalization and clustering. Different GFP-fusion proteins were targeted to mitochondria through a C-terminal mitochondria-targeting sequence domain (MTD) in U2OS cells. Representative immunofluorescence images are shown for each polypeptide, stained for GFP, Tom20, as a mitochondrial marker, and DAPI. Note that the S102D mutation favors clustering in a similar manner to the constitutively active BICD2 N-terminus (BICD2 1–575). Scale bar, 10 µm. See also Supplementary Fig. , showing that clustering happens around the centrosomes. Quantification of the percentage of cells with clustered mitochondria (as defined as cells in which most mitochondria are spatially grouped in one or few clusters in the cytoplasm) for each different GFP-fusion form is shown ( n = 3 biological replicates, 50 cells each; individual replicate means plus mean of replicates ± SD are shown; statistical significance analyzed using a Chi square test, with a two-sided P value; WT vs. S102A, P = 0.0464 (*); WT vs. S102D, P = 0.0010 (**); WT vs. 1–575, P < 0.0001 (***); S012A vs. S102D P < 0.0001 (***)). Expression levels of the different polypeptides as detected by western blot are shown.

Article Snippet: Primary antibodies and dilutions used were as follows: α-PLK1 (mouse monoclonal IgG2b, Calbiochem #DR1037; WB, 1:1000). α-BICD2 (rabbit polyclonal, Abcam #ab117818 for western blot (1:1000) and immunoprecipitations (IP); for immunofluorescence (1:300), rabbit polyclonal #2293, a gift from Anna Akhmanova (Utrecht University), described in ref. ). α-GFP (mouse monoclonal IgG2a, Thermo Fisher #A11120; WB, 1:1000; IF, 1:1000); rabbit polyclonal Torrey Pines #TP401 (IF: 1:500) and Santa Cruz #sc-8334 (IF, 1:500). α-p150 (mouse monoclonal IgG2b, Santa Cruz #sc-365274; WB, 1:1000). α-DIC (mouse monoclonal IgG2b, Santa Cruz #sc-13524 for WB (1:1000) and IP; mouse monoclonal IgG2b, Thermo Fisher #14- 97772-80 for IF(1:500)). α-GST (mouse monoclonal IgG1, Sigma #SAB4200237; WB: 1:1000). α-GAPDH (mouse monoclonal IgG1, Santa Cruz #sc-47724; WB: 1:1000). α-Tom20 (mouse monoclonal IgG2a, Santa Cruz #sc-17764; IF, 1:250). α-PCNT (rabbit polyclonal, Abcam #ab4448; IF: 1:1000). α-CycB (mouse monoclonal IgG1, Santa Cruz #sc-245; IF: 1:2000) Secondary antibodies used were as follows (Alexa Fluor conjugates, Thermo Fisher; HRP conjugates, R&D): Alexa Fluor 647 goat anti-rabbit IgG (H + L) #A21244 (IF: 1:500–1:1000).

Techniques: Mutagenesis, Binding Assay, Immunoprecipitation, Western Blot, Expressing, Sequencing, Immunofluorescence, Staining, Marker

( A ) Schematic of mosaic Ath5 expression in the retina (green) at 28 hpf. Injection of ath5:GFP-CAAX construct at 1 cell stage. ( B ) Example of an asymmetric multipotent progenitor division with regards to Ath5 expression onset. hsp70:H2B-RFP (nuclei, grey), hsp70:mkate2-ras (cell membrane, grey), ath5:GFP-CAAX (Ath5, green). Dashed lines show apical and basal sides of the retinal neuroepithelium. Scale bar, 10 μm. Magenta and yellow dots label sister cells. ( C–C’ ) Schematics of multipotent progenitor cells dividing asymmetrically ( C ) or symmetrically ( C’ ) with regards to Ath5 expression. ( D ) Distribution of asymmetric vs symmetric divisions observed in live imaging experiments. N = number of embryos, n = number of divisions. ( E ) Ath5+ cells (grey) at 36 hpf in control (left) vs Notch inhibition (right). Scale bar, 50 μm. The yellow line delimits the apical side of the retinal neuroepithelium. ( F ) Ath5+ cells (grey) at 48 hpf in control (left) vs Notch inhibition (right). Scale bar, 50 μm. The yellow line delimits the apical side of the retinal neuroepithelium. ( G ) Schematic of retinal neuroepithelium measurements at 48 hpf, ( G’ ) retinal thickness control vs Notch inhibition, ( G’’ ) retinal diameter control vs Notch inhibition. Mann-Whitney test used for comparison. Vertical bars represent standard deviation. ( H ) Example of symmetric progenitor division upon Notch inhibition. hsp70:H2B-RFP (nuclei, grey), ath5:GFP-CAAX (Ath5, green). Dashed lines show apical and basal sides of the retinal neuroepithelium. Scale bar, 10 μm. Magenta and yellow dots label sister cells. ( I ) Distribution of asymmetric vs symmetric divisions observed in live imaging experiments in Notch inhibition compared to controls. Figure 1—source data 1. Source data for panels G’,G’’.

Journal: eLife

Article Title: Asymmetric neurogenic commitment of retinal progenitors involves Notch through the endocytic pathway

doi: 10.7554/eLife.60462

Figure Lengend Snippet: ( A ) Schematic of mosaic Ath5 expression in the retina (green) at 28 hpf. Injection of ath5:GFP-CAAX construct at 1 cell stage. ( B ) Example of an asymmetric multipotent progenitor division with regards to Ath5 expression onset. hsp70:H2B-RFP (nuclei, grey), hsp70:mkate2-ras (cell membrane, grey), ath5:GFP-CAAX (Ath5, green). Dashed lines show apical and basal sides of the retinal neuroepithelium. Scale bar, 10 μm. Magenta and yellow dots label sister cells. ( C–C’ ) Schematics of multipotent progenitor cells dividing asymmetrically ( C ) or symmetrically ( C’ ) with regards to Ath5 expression. ( D ) Distribution of asymmetric vs symmetric divisions observed in live imaging experiments. N = number of embryos, n = number of divisions. ( E ) Ath5+ cells (grey) at 36 hpf in control (left) vs Notch inhibition (right). Scale bar, 50 μm. The yellow line delimits the apical side of the retinal neuroepithelium. ( F ) Ath5+ cells (grey) at 48 hpf in control (left) vs Notch inhibition (right). Scale bar, 50 μm. The yellow line delimits the apical side of the retinal neuroepithelium. ( G ) Schematic of retinal neuroepithelium measurements at 48 hpf, ( G’ ) retinal thickness control vs Notch inhibition, ( G’’ ) retinal diameter control vs Notch inhibition. Mann-Whitney test used for comparison. Vertical bars represent standard deviation. ( H ) Example of symmetric progenitor division upon Notch inhibition. hsp70:H2B-RFP (nuclei, grey), ath5:GFP-CAAX (Ath5, green). Dashed lines show apical and basal sides of the retinal neuroepithelium. Scale bar, 10 μm. Magenta and yellow dots label sister cells. ( I ) Distribution of asymmetric vs symmetric divisions observed in live imaging experiments in Notch inhibition compared to controls. Figure 1—source data 1. Source data for panels G’,G’’.

Article Snippet: Recombinant DNA reagent , hsp70:mKate2-dynactin (1-811) (plasmid DNA) , , RRID: Addgene_105970 , 15 ng/μl.

Techniques: Expressing, Injection, Construct, Membrane, Imaging, Control, Inhibition, MANN-WHITNEY, Comparison, Standard Deviation

Notch inhibition affects progenitor division patterns. ( A ) Onset of Ath5 expression (green) in Ath5+ progenitors between divisions. ( B ) Example of Ath5- sister cell followed to next division. hsp70:H2B-RFP (nuclei, grey), ath5:GFP-CAAX (Ath5, green). Scale bar, 10 μm. ( C ) Schematics of lineage tree of Ath5- cell. ( D ) Ath5+ cells (grey) at 36 hpf in control (left) and upon Notch inhibition (right) with DAPT 50 μM. Scale bar, 50 μm. The yellow line delimits the apical side of the retinal neuroepithelium. ( E ) EdU+ cells (grey) at 42 hpf in control (left) and upon Notch inhibition (right) treated with 10 μM LY411575. Scale bar, 50 μm. The yellow lines delimit the apical and basal side of the retinal neuroepithelium. ( F ) Quantification of EdU-positive cells in the central portion of the retina in control (black) and upon Notch inhibition (blue). Unpaired t -test with Welch’s correction. Error bars represent standard deviation.

Journal: eLife

Article Title: Asymmetric neurogenic commitment of retinal progenitors involves Notch through the endocytic pathway

doi: 10.7554/eLife.60462

Figure Lengend Snippet: Notch inhibition affects progenitor division patterns. ( A ) Onset of Ath5 expression (green) in Ath5+ progenitors between divisions. ( B ) Example of Ath5- sister cell followed to next division. hsp70:H2B-RFP (nuclei, grey), ath5:GFP-CAAX (Ath5, green). Scale bar, 10 μm. ( C ) Schematics of lineage tree of Ath5- cell. ( D ) Ath5+ cells (grey) at 36 hpf in control (left) and upon Notch inhibition (right) with DAPT 50 μM. Scale bar, 50 μm. The yellow line delimits the apical side of the retinal neuroepithelium. ( E ) EdU+ cells (grey) at 42 hpf in control (left) and upon Notch inhibition (right) treated with 10 μM LY411575. Scale bar, 50 μm. The yellow lines delimit the apical and basal side of the retinal neuroepithelium. ( F ) Quantification of EdU-positive cells in the central portion of the retina in control (black) and upon Notch inhibition (blue). Unpaired t -test with Welch’s correction. Error bars represent standard deviation.

Article Snippet: Recombinant DNA reagent , hsp70:mKate2-dynactin (1-811) (plasmid DNA) , , RRID: Addgene_105970 , 15 ng/μl.

Techniques: Inhibition, Expressing, Control, Standard Deviation

( A ) Schematic of progenitor cell soma moving along the apicobasal axis between divisions. ( B ) Maximum basal position of sister cells. Paired t -test was used to compare sister cells. Lines connect sister cells. ( C ) Difference in maximum basal position between sister cells. Vertical error bars represent standard deviation. ( D ) Maximum basal position of sister cells in cases in which Ath5+ sister cells translocate more basally (27/35, 78%). ( E ) Maximum basal position of sister cells in cases in which Ath5- sister cells translocate more basally (8/35, 22%). ( F ) Difference in maximum basal position between sister cells, comparing Ath5+ and Ath5- cells at most basal positions. ( G ) Ath5+ progenitor trajectories between divisions. Start = 0 min, mitosis of mother cell. End, onset of cell rounding. ( H ) Ath5- progenitor trajectories between divisions. Start = 0 min, mitosis of mother cell. End, onset of cell rounding. ( I ) Mean + standard deviation of Ath5+ and Ath5- progenitor pooled tracks from panels G (Ath5+, green) and H (Ath5-, grey). ( J ) Asymmetric division upon DN-dynactin overexpression. hsp70:H2B-RFP (nuclei, grey), hsp70:DNdynactin-mKate2 (dynactin, grey) ath5:GFP-CAAX (Ath5, green). Scale bar, 10 μm. Dashed lines show apical and basal sides of the neuroepithelium. Magenta and yellow dots label sister cells. ( K ) Maximum basal position of sister cells upon dynactin inhibition. Paired t -test to compare sister cells. ( L ) Percentage of asymmetric and symmetric divisions observed upon disruption of dynactin function compared to control. Figure 2—source data 1. Source data for panels B, C, D, E, F, G, H and K. .

Journal: eLife

Article Title: Asymmetric neurogenic commitment of retinal progenitors involves Notch through the endocytic pathway

doi: 10.7554/eLife.60462

Figure Lengend Snippet: ( A ) Schematic of progenitor cell soma moving along the apicobasal axis between divisions. ( B ) Maximum basal position of sister cells. Paired t -test was used to compare sister cells. Lines connect sister cells. ( C ) Difference in maximum basal position between sister cells. Vertical error bars represent standard deviation. ( D ) Maximum basal position of sister cells in cases in which Ath5+ sister cells translocate more basally (27/35, 78%). ( E ) Maximum basal position of sister cells in cases in which Ath5- sister cells translocate more basally (8/35, 22%). ( F ) Difference in maximum basal position between sister cells, comparing Ath5+ and Ath5- cells at most basal positions. ( G ) Ath5+ progenitor trajectories between divisions. Start = 0 min, mitosis of mother cell. End, onset of cell rounding. ( H ) Ath5- progenitor trajectories between divisions. Start = 0 min, mitosis of mother cell. End, onset of cell rounding. ( I ) Mean + standard deviation of Ath5+ and Ath5- progenitor pooled tracks from panels G (Ath5+, green) and H (Ath5-, grey). ( J ) Asymmetric division upon DN-dynactin overexpression. hsp70:H2B-RFP (nuclei, grey), hsp70:DNdynactin-mKate2 (dynactin, grey) ath5:GFP-CAAX (Ath5, green). Scale bar, 10 μm. Dashed lines show apical and basal sides of the neuroepithelium. Magenta and yellow dots label sister cells. ( K ) Maximum basal position of sister cells upon dynactin inhibition. Paired t -test to compare sister cells. ( L ) Percentage of asymmetric and symmetric divisions observed upon disruption of dynactin function compared to control. Figure 2—source data 1. Source data for panels B, C, D, E, F, G, H and K. .

Article Snippet: Recombinant DNA reagent , hsp70:mKate2-dynactin (1-811) (plasmid DNA) , , RRID: Addgene_105970 , 15 ng/μl.

Techniques: Standard Deviation, Over Expression, Inhibition, Disruption, Control

( A ) Asymmetric inheritance of basal process during progenitor division. hsp70:mKate2-ras labels cell membrane (grey). Arrowheads: basal process. Scale bar, 10 μm. Magenta and yellow dots label sister cells. Dashed lines show apical and basal side of retinal neuroepithelium. ( B ) Mean square displacement (MSD) for Ath5+ and Ath5- progenitors, calculated for basal translocation within the first 100 min after mitosis of the mother cell. Data from . ( C ) Maximum basal position of sister cells not inheriting the basal process (No BP) vs inheriting the basal process (BP) after division. ( D ) Proportion of Ath5+ and Ath5- progenitor cells inheriting the basal process. ( E ) Acetylated tubulin staining (magenta) of Tg(ath5:gap-GFP, cyan) with nuclei labelled by DAPI (grey) at 24 (upper left panel), 28 (upper right), 32 (bottom left) and 36 hpf (bottom right). Scale bar, 30 μm. Arrows mark acetylated tubulin staining in the primary cilium (upper left), retinal progenitors (upper right and bottom left) and retinal ganglion cells (bottom right). Dashed lines show apical and basal sides of the retinal neuroepithelium. ( F ) Example of basal translocation of progenitors upon Stathmin1 overexpression induced at 28 hpf. hsp70:Stathmin1-mKate2 (stathmin, grey), ath5:GFP-CAAX (Ath5, green). Scale bar, 5 μm. Magenta and yellow dots label sister cells. Dashed lines show apical and basal sides of the retinal neuroepithelium. ( G ) Percentage of asymmetric and symmetric divisions observed upon Stathmin1 overexpression compared to control. ( H ) Ath5- progenitor trajectories between divisions upon Stathmin1 overexpression. Start = 0 min, mitosis of mother cell. End, onset of cell rounding. ( I ) Ath5+ progenitor trajectories between divisions upon Stathmin1 overexpression. Start = 0 min, mitosis of mother cell. End, onset of cell rounding. ( J ) Mean and Standard Deviation of Ath5- progenitor trajectories in control (magenta) and Stathmin1 overexpression (grey). ( K ) Mean and Standard Deviation of Ath5+ progenitor trajectories in control (light green) and Stathmin1 overexpression (dark green). Figure 4—source data 1. Source data for panels B, C, H and I.

Journal: eLife

Article Title: Asymmetric neurogenic commitment of retinal progenitors involves Notch through the endocytic pathway

doi: 10.7554/eLife.60462

Figure Lengend Snippet: ( A ) Asymmetric inheritance of basal process during progenitor division. hsp70:mKate2-ras labels cell membrane (grey). Arrowheads: basal process. Scale bar, 10 μm. Magenta and yellow dots label sister cells. Dashed lines show apical and basal side of retinal neuroepithelium. ( B ) Mean square displacement (MSD) for Ath5+ and Ath5- progenitors, calculated for basal translocation within the first 100 min after mitosis of the mother cell. Data from . ( C ) Maximum basal position of sister cells not inheriting the basal process (No BP) vs inheriting the basal process (BP) after division. ( D ) Proportion of Ath5+ and Ath5- progenitor cells inheriting the basal process. ( E ) Acetylated tubulin staining (magenta) of Tg(ath5:gap-GFP, cyan) with nuclei labelled by DAPI (grey) at 24 (upper left panel), 28 (upper right), 32 (bottom left) and 36 hpf (bottom right). Scale bar, 30 μm. Arrows mark acetylated tubulin staining in the primary cilium (upper left), retinal progenitors (upper right and bottom left) and retinal ganglion cells (bottom right). Dashed lines show apical and basal sides of the retinal neuroepithelium. ( F ) Example of basal translocation of progenitors upon Stathmin1 overexpression induced at 28 hpf. hsp70:Stathmin1-mKate2 (stathmin, grey), ath5:GFP-CAAX (Ath5, green). Scale bar, 5 μm. Magenta and yellow dots label sister cells. Dashed lines show apical and basal sides of the retinal neuroepithelium. ( G ) Percentage of asymmetric and symmetric divisions observed upon Stathmin1 overexpression compared to control. ( H ) Ath5- progenitor trajectories between divisions upon Stathmin1 overexpression. Start = 0 min, mitosis of mother cell. End, onset of cell rounding. ( I ) Ath5+ progenitor trajectories between divisions upon Stathmin1 overexpression. Start = 0 min, mitosis of mother cell. End, onset of cell rounding. ( J ) Mean and Standard Deviation of Ath5- progenitor trajectories in control (magenta) and Stathmin1 overexpression (grey). ( K ) Mean and Standard Deviation of Ath5+ progenitor trajectories in control (light green) and Stathmin1 overexpression (dark green). Figure 4—source data 1. Source data for panels B, C, H and I.

Article Snippet: Recombinant DNA reagent , hsp70:mKate2-dynactin (1-811) (plasmid DNA) , , RRID: Addgene_105970 , 15 ng/μl.

Techniques: Membrane, Translocation Assay, Staining, Over Expression, Control, Standard Deviation

( A ) Co-localisation of Sara-positive endosomes (RFP-Sara, magenta) and DeltaC staining (cyan) in 36 hpf embryos. Scale bar, 10 μm. Dashed line represents the apical side. ( A’ ) Close-up of co-localisation. Scale bar, 5 μm. ( B ) Co-localisation of Sara-positive endosomes (RFP-Sara, magenta) and Notch1b staining (cyan) in 36 hpf embryos. Scale bar, 10 μm. Dashed line represents the apical side. ( B’ ) Close-up of co-localisation. Scale bar, 5 μm. ( C ) Asymmetric distribution of Sara-positive endosomes in dividing progenitor cells in three different embryos fixed at three different developmental stages, 24, 28 and 36 hpf. Tg(actb1:HRAS-EGFP) (membrane, magenta), RFP-Sara (Sara-positive endosomes, cyan), DAPI (chromatin, grey). Scale bar, 10 μm. ( D ) Number of endosomes within dividing cells. n = 25 cells, 7 embryos. ( D’ ) Histogram of endosomal ratio between dividing cells. n = 25 cells, 7 embryos. ( E ) Asymmetric distribution of Sara-positive endosomes in dividing cells in live samples at 32 hpf. hsp70:mkate2-ras (membrane [grey], CFP-Sara [Sara-positive endosomes, cyan]). Scale bar, 10 μm. Arrowheads point to the endsosomes ( E’ ) YZ (left) and XZ (right) view of sister cells (grey) and Sara endosomes (cyan) at minute 3:00. Scale bar, 10 μm. Arrowheads point to the endsosomes. ( F ) Ath5+ cells (grey) in retinal neuroepithelium at 36 hpf in control (left) and Sara knockdown (Sara-MO, right). Scale bar, 50 μm. The yellow line delimits the apical side of the retinal neuroepithelium. ( F’ ) Tp1+ cells (grey) at 36 hpf in control (left) and Sara morpholino knockdown (right). Scale bar, 30 μm. The yellow line delimits the apical side of the retinal neuroepithelium and the lens. ( G ) Scheme recapitulating the main findings of this study presenting a working model for Sara-positive endosomes inheritance and its role in asymmetric divisions.

Journal: eLife

Article Title: Asymmetric neurogenic commitment of retinal progenitors involves Notch through the endocytic pathway

doi: 10.7554/eLife.60462

Figure Lengend Snippet: ( A ) Co-localisation of Sara-positive endosomes (RFP-Sara, magenta) and DeltaC staining (cyan) in 36 hpf embryos. Scale bar, 10 μm. Dashed line represents the apical side. ( A’ ) Close-up of co-localisation. Scale bar, 5 μm. ( B ) Co-localisation of Sara-positive endosomes (RFP-Sara, magenta) and Notch1b staining (cyan) in 36 hpf embryos. Scale bar, 10 μm. Dashed line represents the apical side. ( B’ ) Close-up of co-localisation. Scale bar, 5 μm. ( C ) Asymmetric distribution of Sara-positive endosomes in dividing progenitor cells in three different embryos fixed at three different developmental stages, 24, 28 and 36 hpf. Tg(actb1:HRAS-EGFP) (membrane, magenta), RFP-Sara (Sara-positive endosomes, cyan), DAPI (chromatin, grey). Scale bar, 10 μm. ( D ) Number of endosomes within dividing cells. n = 25 cells, 7 embryos. ( D’ ) Histogram of endosomal ratio between dividing cells. n = 25 cells, 7 embryos. ( E ) Asymmetric distribution of Sara-positive endosomes in dividing cells in live samples at 32 hpf. hsp70:mkate2-ras (membrane [grey], CFP-Sara [Sara-positive endosomes, cyan]). Scale bar, 10 μm. Arrowheads point to the endsosomes ( E’ ) YZ (left) and XZ (right) view of sister cells (grey) and Sara endosomes (cyan) at minute 3:00. Scale bar, 10 μm. Arrowheads point to the endsosomes. ( F ) Ath5+ cells (grey) in retinal neuroepithelium at 36 hpf in control (left) and Sara knockdown (Sara-MO, right). Scale bar, 50 μm. The yellow line delimits the apical side of the retinal neuroepithelium. ( F’ ) Tp1+ cells (grey) at 36 hpf in control (left) and Sara morpholino knockdown (right). Scale bar, 30 μm. The yellow line delimits the apical side of the retinal neuroepithelium and the lens. ( G ) Scheme recapitulating the main findings of this study presenting a working model for Sara-positive endosomes inheritance and its role in asymmetric divisions.

Article Snippet: Recombinant DNA reagent , hsp70:mKate2-dynactin (1-811) (plasmid DNA) , , RRID: Addgene_105970 , 15 ng/μl.

Techniques: Staining, Membrane, Control, Knockdown

( A ) Ath5+ cells (grey) in the retinal neuroepithelium at 36 hpf in embryos injected with control-MO (upper row) and 2.5 ng/embryo Sara-MO (lower row). Scale bar, 50 μm. The yellow lines delimit the apical and basal side of the retinal neuroepithelium. ( B ) pH3 staining (cyan) in 36 hpf Tg(ath5:gap-GFP) embryos (grey) injected with control-MO (upper row) and 2.5 ng/embryo Sara-MO (lower row). Scale bar, 50 μm. The yellow lines delimit the apical side of the retinal neuroepithelium. ( C ) EdU+ cells (grey) at 36 hpf in control (upper row) and upon Sara knockdown (lower row) in Tg(ath5:gap-GFP) embryos (green). Scale bar, 50 μm. ( D ) Quantification of EdU-positive cells in the central portion of the retina in control (black) and Sara knockdown (blue). Unpaired t -test with Welch’s correction. Error bars represent standard deviation. ( E ) Example of an asymmetric inheritance of Sara-positive endosomes (left) within asymmetric division of multipotent progenitors generating Ath5+ progenitors (right). hsp70:mkate2-ras (cells membrane, grey), CFP-Sara (Sara-positive endosomes, cyan), ath5:GFP-CAAX (Ath5, green). Dashed lines show apical and basal sides of the retinal neuroepithelium. Scale bar, 10 μm. Magenta and yellow dots label sister cells. White arrow points to the Sara-positive endosome.

Journal: eLife

Article Title: Asymmetric neurogenic commitment of retinal progenitors involves Notch through the endocytic pathway

doi: 10.7554/eLife.60462

Figure Lengend Snippet: ( A ) Ath5+ cells (grey) in the retinal neuroepithelium at 36 hpf in embryos injected with control-MO (upper row) and 2.5 ng/embryo Sara-MO (lower row). Scale bar, 50 μm. The yellow lines delimit the apical and basal side of the retinal neuroepithelium. ( B ) pH3 staining (cyan) in 36 hpf Tg(ath5:gap-GFP) embryos (grey) injected with control-MO (upper row) and 2.5 ng/embryo Sara-MO (lower row). Scale bar, 50 μm. The yellow lines delimit the apical side of the retinal neuroepithelium. ( C ) EdU+ cells (grey) at 36 hpf in control (upper row) and upon Sara knockdown (lower row) in Tg(ath5:gap-GFP) embryos (green). Scale bar, 50 μm. ( D ) Quantification of EdU-positive cells in the central portion of the retina in control (black) and Sara knockdown (blue). Unpaired t -test with Welch’s correction. Error bars represent standard deviation. ( E ) Example of an asymmetric inheritance of Sara-positive endosomes (left) within asymmetric division of multipotent progenitors generating Ath5+ progenitors (right). hsp70:mkate2-ras (cells membrane, grey), CFP-Sara (Sara-positive endosomes, cyan), ath5:GFP-CAAX (Ath5, green). Dashed lines show apical and basal sides of the retinal neuroepithelium. Scale bar, 10 μm. Magenta and yellow dots label sister cells. White arrow points to the Sara-positive endosome.

Article Snippet: Recombinant DNA reagent , hsp70:mKate2-dynactin (1-811) (plasmid DNA) , , RRID: Addgene_105970 , 15 ng/μl.

Techniques: Injection, Control, Staining, Knockdown, Standard Deviation, Membrane

DNA constructs used in this study.

Journal: eLife

Article Title: Asymmetric neurogenic commitment of retinal progenitors involves Notch through the endocytic pathway

doi: 10.7554/eLife.60462

Figure Lengend Snippet: DNA constructs used in this study.

Article Snippet: Recombinant DNA reagent , hsp70:mKate2-dynactin (1-811) (plasmid DNA) , , RRID: Addgene_105970 , 15 ng/μl.

Techniques: Construct, Concentration Assay

Journal: eLife

Article Title: Asymmetric neurogenic commitment of retinal progenitors involves Notch through the endocytic pathway

doi: 10.7554/eLife.60462

Figure Lengend Snippet:

Article Snippet: Recombinant DNA reagent , hsp70:mKate2-dynactin (1-811) (plasmid DNA) , , RRID: Addgene_105970 , 15 ng/μl.

Techniques: Recombinant, Plasmid Preparation, Sequencing, Control, Software, Microscopy

Fignl1 directly binds the dynein/dynactin motor adaptor bicd1 in a protein complex including KIF1Bβ and dynactin 1. (A) Schematic representation of Ms_fignl1, Ms_bicd1, and their respective binding domains identified through a yeast two-hybrid screen (Y2H; black arrows). Specific domains are shown as boxes. Numbers indicate amino acids that delineate domain frontiers. AAA, ATPase domain; CC1, CC2, and CC3, coil-coiled domains. (B) COS-7 cells transfected with GFP-Ms_bicd1 and Dr_Fignl1-HA, and immunolabeled with HA and GFP antibodies. Dashed line delimits the transfected cell. Bottom panels represent higher magnifications of boxed regions in corresponding upper panels. Arrowheads indicate colocalization between HA-Fignl1 and GFP-bicd1 onto cytoplasmic vesicles. Scale bars, 10 µm. (C) Fignl1 associates with bicd1. Co-IP of Fignl1 isoforms and bicd1 from protein extracts of COS-7 cells transfected with GFP-Ms_bicd1 or GFP, Ms_ HA-fignl1, Dr_Fignl1-HA, or Dr_Fignl1Δ1-113-HA. (D) KIF1Bβ associates with bicd1. Co-IP of KIF1Bβ and bicd1 from protein extracts of COS-7 cells transfected with YFP-Hu_KIF1Bβ and Flag-Ms_bicd1. (E and F) Fignl1 is part of a protein complex including KIF1Bβ and the dynein adaptors bicd1 (E) and dynactin 1 (F). (E) Left-hand well: Co-IP of exogenous Fignl1 and bicd1 with endogenous kif1b from protein extracts of COS-7 cells transfected with Dr_Fignl1-HA and GFP-Ms_bicd1. Middle and right-hand wells: Co-IP of exogenous Fignl1, bicd1, and KIF1Bβ from protein extracts of COS-7 cells transfected with Dr_Fignl1-HA, Flag-Ms_bicd1, and YFP-Hu_KIF1Bβ or GFP. Immunoprecipitations were performed with GFP-trap (C–F), KIF1B (E), or HA (F) antibodies. Immunoprecipitated and coimmunoprecipitated proteins were revealed by Western blot using anti-tag or KIF1B and dynactin 1 antibodies or by Ponceau staining. IP, immunoprecipitation; WB, Western blot.

Journal: The Journal of Cell Biology

Article Title: FIGNL1 associates with KIF1Bβ and BICD1 to restrict dynein transport velocity during axon navigation

doi: 10.1083/jcb.201805128

Figure Lengend Snippet: Fignl1 directly binds the dynein/dynactin motor adaptor bicd1 in a protein complex including KIF1Bβ and dynactin 1. (A) Schematic representation of Ms_fignl1, Ms_bicd1, and their respective binding domains identified through a yeast two-hybrid screen (Y2H; black arrows). Specific domains are shown as boxes. Numbers indicate amino acids that delineate domain frontiers. AAA, ATPase domain; CC1, CC2, and CC3, coil-coiled domains. (B) COS-7 cells transfected with GFP-Ms_bicd1 and Dr_Fignl1-HA, and immunolabeled with HA and GFP antibodies. Dashed line delimits the transfected cell. Bottom panels represent higher magnifications of boxed regions in corresponding upper panels. Arrowheads indicate colocalization between HA-Fignl1 and GFP-bicd1 onto cytoplasmic vesicles. Scale bars, 10 µm. (C) Fignl1 associates with bicd1. Co-IP of Fignl1 isoforms and bicd1 from protein extracts of COS-7 cells transfected with GFP-Ms_bicd1 or GFP, Ms_ HA-fignl1, Dr_Fignl1-HA, or Dr_Fignl1Δ1-113-HA. (D) KIF1Bβ associates with bicd1. Co-IP of KIF1Bβ and bicd1 from protein extracts of COS-7 cells transfected with YFP-Hu_KIF1Bβ and Flag-Ms_bicd1. (E and F) Fignl1 is part of a protein complex including KIF1Bβ and the dynein adaptors bicd1 (E) and dynactin 1 (F). (E) Left-hand well: Co-IP of exogenous Fignl1 and bicd1 with endogenous kif1b from protein extracts of COS-7 cells transfected with Dr_Fignl1-HA and GFP-Ms_bicd1. Middle and right-hand wells: Co-IP of exogenous Fignl1, bicd1, and KIF1Bβ from protein extracts of COS-7 cells transfected with Dr_Fignl1-HA, Flag-Ms_bicd1, and YFP-Hu_KIF1Bβ or GFP. Immunoprecipitations were performed with GFP-trap (C–F), KIF1B (E), or HA (F) antibodies. Immunoprecipitated and coimmunoprecipitated proteins were revealed by Western blot using anti-tag or KIF1B and dynactin 1 antibodies or by Ponceau staining. IP, immunoprecipitation; WB, Western blot.

Article Snippet: Stockdale, Stanford University School of Medicine, Stanford, CA), mouse RMO44 (130500; Invitrogen), rabbit Fignl1 3353 , rabbit GFP (A11122; Invitrogen), Alexa Fluor 488–conjugated phalloidin (A12379; Invitrogen), mouse tyrosinated tubulin (T9028; Sigma-Aldrich), rat HA (11867423001; Roche), rabbit Flag (F7425; Sigma-Aldrich), rabbit KIF1B (sc-376246; Santa Cruz Biotechnology), and mouse dynactin 1 (610473; BD Transduction Laboratories).

Techniques: Binding Assay, Two Hybrid Screening, Transfection, Immunolabeling, Co-Immunoprecipitation Assay, Immunoprecipitation, Western Blot, Staining

Fignl1-mediated restriction of dynein activity is required for accurate navigation of RoP-like sMN axons. (A and B) Immunolabeling of sMN axons in 56-hpf WT larvae treated at 46 hpf with 4 µM of the dynein inhibitor Ciliobrevin D or its vehicle (DMSO) using the Zn-5 antibody. (B) Quantification of the mean number of missing rostral nerves in Ciliobrevin- and DMSO-treated WT larvae. (C) Immunolabeling of sMN in 56-hpf WT and dynactin1b −/− mutant larvae. (D and E) Mean number of mistargeted (i.e., caudally oriented; D) or missing (E) rostral nerves in control and mutant larvae. (F) Analysis of sMN in 56-hpf control and Fignl1-overexpressing larvae. (A–F) Loss of dynein or dynactin 1b function leads to sMN axon pathfinding defects that reproduce those observed in Fignl1-overexpressing embryos. (G) Immunolabeling of sMN axons in 56-hpf Fignl1 morphant larvae treated with 1 µM Ciliobrevin D or DMSO. (H) Mean number of defasciculated/split rostral nerves in Ciliobrevin D– or DMSO-treated larvae. Pharmacological reduction of dynein activity partially rescues the axon pathfinding defects of RoP-like sMN axons in Fignl1-depleted larvae. (A, C, F, and G) Empty arrowheads indicate normal rostral nerves. Arrowheads and arrows, respectively, point at misguided and missing (A, C, and F) or defasciculated/split (G) rostral nerves. Scale bars, 40 µm. (B, D, E, and H) Quantifications were performed in 24 spinal hemisegments of 28 DMSO-treated and 27 Ciliobrevin D–treated control larvae (B), 39 WT and 37 dynactin1b −/− mutant larvae (D and E), and 36 DMSO-treated and 36 Ciliobrevin D–treated Fignl1 morphant larvae (H) pooled from three independent experiments. **, P ≤ 0.01; ***, P ≤ 0.001; ns, nonsignificant; Mann–Whitney test (B, D, E, and H). Error bars are SEM.

Journal: The Journal of Cell Biology

Article Title: FIGNL1 associates with KIF1Bβ and BICD1 to restrict dynein transport velocity during axon navigation

doi: 10.1083/jcb.201805128

Figure Lengend Snippet: Fignl1-mediated restriction of dynein activity is required for accurate navigation of RoP-like sMN axons. (A and B) Immunolabeling of sMN axons in 56-hpf WT larvae treated at 46 hpf with 4 µM of the dynein inhibitor Ciliobrevin D or its vehicle (DMSO) using the Zn-5 antibody. (B) Quantification of the mean number of missing rostral nerves in Ciliobrevin- and DMSO-treated WT larvae. (C) Immunolabeling of sMN in 56-hpf WT and dynactin1b −/− mutant larvae. (D and E) Mean number of mistargeted (i.e., caudally oriented; D) or missing (E) rostral nerves in control and mutant larvae. (F) Analysis of sMN in 56-hpf control and Fignl1-overexpressing larvae. (A–F) Loss of dynein or dynactin 1b function leads to sMN axon pathfinding defects that reproduce those observed in Fignl1-overexpressing embryos. (G) Immunolabeling of sMN axons in 56-hpf Fignl1 morphant larvae treated with 1 µM Ciliobrevin D or DMSO. (H) Mean number of defasciculated/split rostral nerves in Ciliobrevin D– or DMSO-treated larvae. Pharmacological reduction of dynein activity partially rescues the axon pathfinding defects of RoP-like sMN axons in Fignl1-depleted larvae. (A, C, F, and G) Empty arrowheads indicate normal rostral nerves. Arrowheads and arrows, respectively, point at misguided and missing (A, C, and F) or defasciculated/split (G) rostral nerves. Scale bars, 40 µm. (B, D, E, and H) Quantifications were performed in 24 spinal hemisegments of 28 DMSO-treated and 27 Ciliobrevin D–treated control larvae (B), 39 WT and 37 dynactin1b −/− mutant larvae (D and E), and 36 DMSO-treated and 36 Ciliobrevin D–treated Fignl1 morphant larvae (H) pooled from three independent experiments. **, P ≤ 0.01; ***, P ≤ 0.001; ns, nonsignificant; Mann–Whitney test (B, D, E, and H). Error bars are SEM.

Article Snippet: Stockdale, Stanford University School of Medicine, Stanford, CA), mouse RMO44 (130500; Invitrogen), rabbit Fignl1 3353 , rabbit GFP (A11122; Invitrogen), Alexa Fluor 488–conjugated phalloidin (A12379; Invitrogen), mouse tyrosinated tubulin (T9028; Sigma-Aldrich), rat HA (11867423001; Roche), rabbit Flag (F7425; Sigma-Aldrich), rabbit KIF1B (sc-376246; Santa Cruz Biotechnology), and mouse dynactin 1 (610473; BD Transduction Laboratories).

Techniques: Activity Assay, Immunolabeling, Mutagenesis, MANN-WHITNEY

Hypothetical model of Fignl1-mediated regulation of dynein-based retrograde transport velocity during motor axon pathfinding. (A and B) Left-hand panels schematize the physiological consequences of Fignl1 loss of function (B) on SMN axon pathfinding compared with normal conditions (A). Schemes represent lateral views of two zebrafish hemisegments, anterior to the left. Ant, anterior; Post, posterior. Boxed right-hand panels focus on the molecular model that might underlie SMN navigational behavior in each condition. (A) In healthy conditions, Fignl1 may promote the recruitment of Kif1bβ onto dynein-bound cargoes—or vice versa—which could decrease the velocity of the dynein/dynactin complex through a tug of war or a cooperative mechanism. Fignl1-mediated inhibition of dynein velocity may then regulate the delivery of cargoes required for accurate rostral nerve targeting. (B) Fignl1 depletion could reduce the number of dynein-attached cargoes associated with Kif1bβ and would thus increase dynein-mediated retrograde axonal transport velocity, ultimately affecting the distribution of cargoes critical for rostral nerve fasciculation and pathfinding.

Journal: The Journal of Cell Biology

Article Title: FIGNL1 associates with KIF1Bβ and BICD1 to restrict dynein transport velocity during axon navigation

doi: 10.1083/jcb.201805128

Figure Lengend Snippet: Hypothetical model of Fignl1-mediated regulation of dynein-based retrograde transport velocity during motor axon pathfinding. (A and B) Left-hand panels schematize the physiological consequences of Fignl1 loss of function (B) on SMN axon pathfinding compared with normal conditions (A). Schemes represent lateral views of two zebrafish hemisegments, anterior to the left. Ant, anterior; Post, posterior. Boxed right-hand panels focus on the molecular model that might underlie SMN navigational behavior in each condition. (A) In healthy conditions, Fignl1 may promote the recruitment of Kif1bβ onto dynein-bound cargoes—or vice versa—which could decrease the velocity of the dynein/dynactin complex through a tug of war or a cooperative mechanism. Fignl1-mediated inhibition of dynein velocity may then regulate the delivery of cargoes required for accurate rostral nerve targeting. (B) Fignl1 depletion could reduce the number of dynein-attached cargoes associated with Kif1bβ and would thus increase dynein-mediated retrograde axonal transport velocity, ultimately affecting the distribution of cargoes critical for rostral nerve fasciculation and pathfinding.

Article Snippet: Stockdale, Stanford University School of Medicine, Stanford, CA), mouse RMO44 (130500; Invitrogen), rabbit Fignl1 3353 , rabbit GFP (A11122; Invitrogen), Alexa Fluor 488–conjugated phalloidin (A12379; Invitrogen), mouse tyrosinated tubulin (T9028; Sigma-Aldrich), rat HA (11867423001; Roche), rabbit Flag (F7425; Sigma-Aldrich), rabbit KIF1B (sc-376246; Santa Cruz Biotechnology), and mouse dynactin 1 (610473; BD Transduction Laboratories).

Techniques: Inhibition